Vaccine-Induced Thrombocytopenia with Severe Headache-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vaccine-Induced Thrombocytopenia with Severe Headache

Published:2021-11-25 Issue:22 Volume:385 Page:2103-2105
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Salih Farid¹,Schönborn Linda²,Kohler Siegfried,Franke Christiana,Möckel Martin,Dörner Thomas^ORCID,Bauknecht Hans C.,Pille Christian,Graw Jan A.,Alonso Angelika³,Pelz Johann⁴,Schneider Hauke,Bayas Antonios,Christ Monika,Kuramatsu Joji B.⁵,Thiele Thomas,Greinacher Andreas^ORCID,Endres Matthias¹

Affiliation:

1. Charité-Universitätsmedizin Berlin, Berlin, Germany

2. Universitätsmedizin Greifswald, Greifswald, Germany

3. University Hospital of Mannheim, Mannheim, Germany

4. University Hospital of Leipzig, Leipzig, Germany

5. University Hospital of Erlangen, Erlangen, Germany

Funder

Deutsche Forschungsgemeinschaft

Universitätsmedizin Greifswald

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc2112974

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and management of the main serious adverse events reported after COVID‐19 vaccination;Pharmacology Research & Perspectives;2024-06

2. Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data;Vaccine;2024-03

3. Therapeutic strategies in FcγIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT);Expert Opinion on Pharmacotherapy;2024-02-11

4. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure;Blood;2023-12-28

5. Harnessing Nanovaccines for Effective Immunization─A Special Concern on COVID-19: Facts, Fidelity, and Future Prospective;ACS Biomaterials Science & Engineering;2023-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3